Eleven Biotherapeutics (EBIO) Completes Merger with Viventia Bio; New CEO Named
Go back to Eleven Biotherapeutics (EBIO) Completes Merger with Viventia Bio; New CEO Named| ELEVEN BIOTHERAP (NASDAQ: EBIO) | Delayed: 3.29 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.29 | 52 Week High | $5.97 | |||
| Open | $54.26 | 52 Week Low | $0.25 | |||
| Day High | $3.29 | P/E | N/A | |||
| Day Low | $3.29 | EPS | $-3.20 | |||
| Volume | 1,110 | |||||
